MedTrace Logo

Health Consequences of the Burden of Atrial Fibrillation

NCT05389228 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 325

Last updated 2024-03-19

No results posted yet for this study

Summary

The Swiss-AF-BURDEN study will be embedded in the follow-up visits of the Swiss-AF cohort study. The research question of the current atrial fibrillation burden will be answered by using 7-day Holter-ECG recordings and continuous implanted loop recorder recording, whereas cardiac MRI examination will give results about cardiac dimensions and function. The 7-day Holter ECG will be repeated after one year. The cMRI will be performed separately or directly after the brain MRI to minimize the additional burden for the patients. Only a subsample of 100 patients will additionally receive ILR for 2 years.

Conditions

Sponsors & Collaborators

  • Swiss National Science Foundation

    collaborator OTHER

  • Clinical Trial Unit, University Hospital Basel, Switzerland

    collaborator OTHER

  • Swiss Heart Foundation

    collaborator OTHER

  • Insel Gruppe AG, University Hospital Bern

    collaborator OTHER

  • University Hospital, Geneva

    collaborator OTHER

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Michael Kuehne, MD Prof, exec MBA · University Hospital, Basel, Switzerland

  • Laurent Roten, MD Prof · University Hospital Insel, Bern, Switzerland

  • Dipen Shah, MD Prof · Hôpitaux Universitaires de Genève, Switzerland

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2024-01-07
Completion
2024-01-07

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05389228 on ClinicalTrials.gov